Pramine and Diplopia - a phase IV clinical study of FDA data

Summary:

Diplopia is reported as a side effect among people who take Pramine (imipramine hydrochloride), especially for people who are female, 60+ old, also take Ditropan, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Diplopia when taking Pramine. It is created by eHealthMe based on reports of 7,187 people who have side effects when taking Pramine from the FDA, and is updated regularly.

What is Pramine?

Pramine has active ingredients of imipramine hydrochloride. eHealthMe is studying from 7,461 Pramine users. Check the latest studies of Pramine.

What is Diplopia?

Diplopia (double vision) is found to be associated with 1,438 drugs and 1,892 conditions by eHealthMe. Check the latest studies of Diplopia.

On Jul, 09, 2026

7,187 people reported to have side effects when taking Pramine.
Among them, 16 people (0.22%) have Diplopia.

Among these 16 people:

What is the gender of people who have Diplopia when taking Pramine? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Diplopia when taking Pramine? *

What are other drugs people take besides Pramine? *

What are other side effects people have besides Diplopia? *

Vision Blurred: 5 people, 31.25%
Dizziness: 5 people, 31.25%
Visual Acuity Reduced (reduced clearness of vision): 4 people, 25.00%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 25.00%
Weakness: 3 people, 18.75%
Constipation: 3 people, 18.75%
Headache (pain in head): 3 people, 18.75%
High Blood Pressure: 3 people, 18.75%
Fatigue (feeling of tiredness): 3 people, 18.75%
Balance Disorder: 3 people, 18.75%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 37.50%
Sleep Disorder: 2 people, 12.50%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 12.50%
Migraine (headache): 2 people, 12.50%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 12.50%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 6.25%
Stress And Anxiety: 1 person, 6.25%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 6.25%
Polyarteritis Nodosa (progressive disease of connective tissue): 1 person, 6.25%
Pain: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Pramine and have Diplopia?

- Check whether Diplopia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pramine:

Pramine (7,461 reports)

Diplopia treatments and more:

Diplopia (32,465 reports)

Browse all side effects of Pramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diplopia:

Diplopia (1,438 drugs)

Browse all the conditions that are associated with Diplopia:

Diplopia (1,892 conditions)

Related publications that referenced our studies

Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on imipramine hydrochloride (the active ingredients of Pramine) and Pramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.